# 68Ga-HER2 Affibody PET/CT Imaging for HER2-Positive Cancer Patients

> **NCT05535621** · — · UNKNOWN · sponsor: **Tongji Hospital** · enrollment: 100 (estimated)

## Conditions studied

- HER2-Positive Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05535621
- **Lead sponsor:** Tongji Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-12-18
- **Primary completion:** 2024-12-30
- **Final completion:** 2025-12-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2023-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05535621

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05535621, "68Ga-HER2 Affibody PET/CT Imaging for HER2-Positive Cancer Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05535621. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*